Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Teba medicin AB
AB
Active
Org 5591434310
Borgarfjord 21 A Lgh 2502
General medical practice activities · NACE 8621
Est. 2018
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 1,1M
+14% vs 2023
EBITDA margin
59.4%
+20% vs 2023
Equity ratio
94.5%
Financial strength
Net profit 2024
SEK 454K
+30% vs 2023
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
0M
2020
1M
+100%
2021
1M
0%
2022
1M
0%
2023
1M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 1,1M
+14%
EBITDA
SEK 646K
+20%
Net profit
SEK 454K
+30%
Total assets
SEK 1,6M
+4%
Equity
SEK 1,5M
+4%
Employees
1
—
Company information
Legal name
Teba medicin AB
Org number
5591434310
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
3 januari 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultläkare på primärvården och sjukhus.
Contact
Address
Borgarfjord 21 A Lgh 2502
Email
motea_m@live.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2020
1M
2021
1M
2022
1M
2023
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
1M
2021
1M
2022
1M
2023
1M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
1 228
1 292
1 090
958
1 088
Staff expenses
—
—
−421
−388
−421
EBITDA
375
671
641
537
646
Depreciation & amort.
−46
−139
−94
−98
−98
EBIT
329
532
546
440
549
Net financials
−1
−2
0
2
24
Profit before tax
328
530
547
441
572
Tax
−70
−110
−113
−91
−118
Net profit
258
420
434
350
454
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 271
1 468
1 479
1 520
1 588
Equity
969
1 212
1 396
1 446
1 500
Long-term debt
0
0
—
—
—
Short-term debt
302
256
83
74
87
Total debt
302
256
83
74
87
Financial ratios
5-year trend
EBITDA margin
59.4%
This company
15.8%
Market median
+276% vs market
2020
2024
Equity ratio
94.5%
This company
38.2%
Market median
+147% vs market
2020
2024
Return on equity
30.3%
This company
18.4%
Market median
+65% vs market
2020
2024
Net profit margin
41.7%
This company
8.1%
Market median
+415% vs market
2020
2024
Asset turnover
0.69×
This company
1.12×
Market median
-38% vs market
2020
2024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
MM
Motea Mezher Rwayyih Rwayyih
Board of Directors
2022
AJ
Amal Jabbar Majid
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Teba medicin AB also hold positions in
0
other companies.
Person
Role here
Other companies
Motea Mezher Rwayyih Rwayyih
Board of Directors
0 companies
Amal Jabbar Majid
Deputy Board Member
0 companies